Bölümler
-
Heather Turner, Policy Analyst at the PHG Foundation, explains for you long-read sequencing, its potential applications and how this new technology measures up against traditional short-read sequencing.
Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.
Heather recently wrote two briefings on long-read sequencing. Both are freely available: Clinical long-read sequencing and Long-read sequencing: Clinical applications and implementation.If you have any questions about the topic then you can email us at [email protected].
-
Dr Sowmiya Moorthie, Senior Policy Analyst at the PHG Foundation, explains polygenic scores, their potential - and their limitations – in predicting risk of common diseases.
Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
Lots more about polygenic scores can be found on the PHG Foundation website phgfoundation.org, where you can also read our latest report on the topic Evaluation of polygenic score applications which was authored by Dr Moorthie.
If you have any questions about the topic then you can email us at [email protected]. -
Eksik bölüm mü var?
-
Dr Chantal Babb de Villiers discusses gene editing animals for organ transplants to humans, otherwise known as xenotransplantation.
Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
You can read Chantal's briefing on xenotransplantation here.
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.
If you have any further questions about the topic then you can email us at [email protected]. -
Dr Hayley Carr discusses inflammatory bowel disease and current research into improving patient care using genetics-driven precision medicine.
Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
You can read Hayley's briefing on precision medicine for inflammatory bowel disease here.
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.
If you have any further questions about the topic then you can email us at [email protected]. -
We are delighted to present Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
In the first episode, Dr Joanna Janus explains the basics of liquid biopsy, its role as an alternative to solid tissue biopsies, and its potential as a tool for monitoring the success of treatments
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.
If you have any further questions about the topic then you can email us at [email protected].
